Aspire Private Capital, LLC Champions Oncology, Inc. Transaction History

Aspire Private Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$4.19 - $8.62 $838 - $1,723	-200 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$5.4 - $8.99 $1,198 - $1,995	-222 Reduced 52.61%	200 $1,000
Q2 2019 Aug 13, 2019	SELL	$7.51 - $10.12 $1,824 - $2,459	-243 Reduced 36.54%	422 $3,000
Q4 2018 Feb 25, 2019	BUY	$7.29 - $15.27 $4,366 - $9,146	599 Added 907.58%	665 $5,000
Q4 2018 Feb 14, 2019	BUY	$7.29 - $15.27 $481 - $1,007	66 New	66 $5,000

5.82M

15K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $113M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspire Private Capital, LLC with notifications on news.